Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study

Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors (ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB and ACEI in their effects on the primary prevention of AF remain unclear. This study compared ARB and ACEI in combined an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Hsieh, Yu-Cheng, Hung, Chen-Ying, Li, Cheng-Hung, Liao, Ying-Chieh, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
3400
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4902433/
https://ncbi.nlm.nih.gov/pubmed/27196491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003721
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados